A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change
Key facts
- Where
- Taipei, TajvanSee the site
Where in Tajvan
- No.7, Chung Shan S. Rd.（Zhongshan S. Rd.）Taipei, TajvanNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Taiwan University Hospital
- Trial code
- NCT07239167
- Record updated
- 2026. szeptember 15.
- Original description
This prospective cohort study collected baseline data and followed up obese patients at their first visit to a weight loss clinic. The study examined the impact of various predictors and biomarkers on weight loss outcomes, aiming to establish an evidence-based foundation for personalized weight loss treatment.Read full original descriptionShow less
This prospective cohort study collected baseline data and followed up obese patients at their first visit to a weight loss clinic. The study examined the impact of various predictors and biomarkers on weight loss outcomes, aiming to establish an evidence-based foundation for personalized weight loss treatment.
Participants underwent a battery of measurements and questionnaires, including height, weight, waist circumference, blood pressure, blood tests, and questionnaires addressing diet, exercise, stress, sleep, measure handgrip strength ,and psychological well-being.
Inclusion: Adults aged 18 years or older, regardless of gender; Body mass index (BMI) ≥ 27 kg/m², or ≥ 24 kg/m² with one or more obesity-related comorbidities; Willing to undergo any form of weight loss intervention; Able to read and understand Chinese, willing to complete questionnaires, blood tests, and follow-up follow-up; Voluntarily consent to participate and be willing to complete the subject consent form.
Exclusion: Individuals taking medications that significantly affect their weight (e.g., long-term steroids or antipsychotics) and cannot be discontinued; Individuals with significant mental illness (e.g., schizophrenia, severe depression) or cognitive impairment that may affect their ability to consent or cooperate with the study; Individuals with severe organ dysfunction (e.g., end-stage renal disease, cirrhosis, congestive heart failure, etc.); Pregnant or breastfeeding women; Individuals deemed unsuitable for participation in this study by the study leader (e.g., individuals who are expected to be unable to complete follow-up).